{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:02:22Z","timestamp":1771351342218,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10072-025-08719-1","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:54:17Z","timestamp":1769226857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the efficacy, methods, and challenges of induced pluripotent stem cells (iPSC) therapy in Parkinson's disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Mohammed Ahmed","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaker","family":"Al-Hasnaawei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irwanjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malathi","family":"H","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-0875","authenticated-orcid":false,"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Dhyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6681-4529","authenticated-orcid":false,"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"1","key":"8719_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"C Olanow","year":"1999","unstructured":"Olanow C, Tatton W (1999) Etiology and pathogenesis of Parkinson\u2019s disease. Annu Rev Neurosci 22(1):123\u2013144","journal-title":"Annu Rev Neurosci"},{"issue":"6","key":"8719_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM De Lau","year":"2006","unstructured":"De Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535","journal-title":"Lancet Neurol"},{"issue":"5","key":"8719_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.62641\/aep.v52i5.1634","volume":"52","author":"Z Wang","year":"2024","unstructured":"Wang Z, Tian J, Dai W, Zhang N, Wang J, Li Z (2024) The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression inParkinson\u2019s Disease: A Retrospective Study. Actas Espa\u00f1\u00f1olas de Psiquiatr\u00ed\u00eda 52(5):607\u2013615. https:\/\/doi.org\/10.62641\/aep.v52i5.1634","journal-title":"Actas Espa\u00f1\u00f1olas de Psiquiatr\u00ed\u00eda"},{"issue":"3","key":"8719_CR4","doi-asserted-by":"publisher","first-page":"9250066","DOI":"10.26599\/FSHW.2024.9250066","volume":"14","author":"B Chang","year":"2025","unstructured":"Chang B, Jiang Y, Feng C, Li B, Mei J, Niu C (2025) Effect of purine diet on prognosis of deep brain stimulation for Parkinson\u2019sdisease. Food Science and Human Wellness 14(3):9250066. https:\/\/doi.org\/10.26599\/FSHW.2024.9250066","journal-title":"Food Science and Human Wellness"},{"key":"8719_CR5","doi-asserted-by":"publisher","first-page":"1511011","DOI":"10.3389\/fphar.2025.1511011","volume":"16","author":"H Luo","year":"2025","unstructured":"Luo H, Wei S, Fu S, Han L (2025) Role of Achyranthesaspera in neurodegenerative diseases: current evidence and future directions. Frontiers in Pharmacology 16:1511011. https:\/\/doi.org\/10.3389\/fphar.2025.1511011","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"8719_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4252\/wjsc.v7.i2.502","volume":"7","author":"S Suksuphew","year":"2015","unstructured":"Suksuphew S, Noisa P (2015) Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases. World J Stem Cells 7(2):502","journal-title":"World J Stem Cells"},{"issue":"5052","key":"8719_CR7","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052):1707\u20131710","journal-title":"Science"},{"issue":"5309","key":"8719_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.276.5309.66","volume":"276","author":"R McKay","year":"1997","unstructured":"McKay R (1997) Stem cells in the central nervous system. Science 276(5309):66\u201371","journal-title":"Science"},{"issue":"6","key":"8719_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1006\/mcne.1998.0721","volume":"12","author":"M Takahashi","year":"1998","unstructured":"Takahashi M, Palmer TD, Takahashi J, Gage FH (1998) Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina. Mol Cell Neurosci 12(6):340\u2013348","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"8719_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/(SICI)1097-4695(199808)36:2<152::AID-NEU4>3.0.CO;2-0","volume":"36","author":"N Gaiano","year":"1998","unstructured":"Gaiano N, Fishell G (1998) Transplantation as a tool to study progenitors within the vertebrate nervous system. J Neurobiol 36(2):152\u2013161","journal-title":"J Neurobiol"},{"issue":"4","key":"8719_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663\u2013676","journal-title":"Cell"},{"issue":"2","key":"8719_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nprot.2009.241","volume":"5","author":"T Aasen","year":"2010","unstructured":"Aasen T, Belmonte JCI (2010) Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 5(2):371\u2013382","journal-title":"Nat Protoc"},{"issue":"4","key":"8719_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.stem.2009.08.021","volume":"5","author":"A Haase","year":"2009","unstructured":"Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C et al (2009) Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5(4):434\u2013441","journal-title":"Cell Stem Cell"},{"issue":"22","key":"8719_CR14","first-page":"5476","volume":"113","author":"Y-H Loh","year":"2009","unstructured":"Loh Y-H, Agarwal S, Park I-H, Urbach A, Huo H, Heffner GC et al (2009) Generation of induced pluripotent stem cells from human blood. Blood, J Am Soc Hematol3 113(22):5476\u20135479","journal-title":"Blood, J Am Soc Hematol3"},{"key":"8719_CR15","doi-asserted-by":"publisher","first-page":"1566670","DOI":"10.3389\/fcell.2025.1566670","volume":"13","author":"X Tao","year":"2025","unstructured":"Tao X, Wang J, Yan Y, Cheng P, Liu B, Du H, Niu B (2025) Optimal Sca-1-based procedure for purifying mouse adipose-derived mesenchymal stemcells with enhanced proliferative and differentiation potential. Front. Cell Dev. Biol. 13:1566670. https:\/\/doi.org\/10.3389\/fcell.2025.1566670","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"8719_CR16","first-page":"7527","volume":"13","author":"SW Li","year":"2020","unstructured":"Li SW, Kuang ZD, Kuang WP (2020) Protective effect of gastrodin on dopaminergic neurons by miR-24 targeting of the DJ-1\/Nrf2 pathway in Parkinson\u2019s disease. Int J Clin Exp Med 13(10):7527\u20137535","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"8719_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrg2937","volume":"12","author":"F Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez F, Bou\u00e9 S, Belmonte JCI (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12(4):231\u2013242","journal-title":"Nat Rev Genet"},{"issue":"10","key":"8719_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"CR Freed","year":"2001","unstructured":"Freed CR, Greene PE, Breeze RE, Tsai W-Y, DuMouchel W, Kao R et al (2001) Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N Engl J Med 344(10):710\u2013719","journal-title":"N Engl J Med"},{"issue":"3","key":"8719_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","volume":"54","author":"CW Olanow","year":"2003","unstructured":"Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF et al (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease. Ann Neurol 54(3):403\u2013414","journal-title":"Ann Neurol"},{"key":"8719_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0079-6123(10)84014-2","volume":"184","author":"P Brundin","year":"2010","unstructured":"Brundin P, Barker RA, Parmar M (2010) Neural grafting in Parkinson\u2019s disease: problems and possibilities. Prog Brain Res 184:265\u2013294","journal-title":"Prog Brain Res"},{"issue":"7","key":"8719_CR21","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","volume":"128","author":"I Mendez","year":"2005","unstructured":"Mendez I, Sanchez-Pernaute R, Cooper O, Vi\u00f1uela A, Ferrari D, Bj\u00f6rklund L et al (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease. Brain 128(7):1498\u20131510","journal-title":"Brain"},{"key":"8719_CR22","doi-asserted-by":"crossref","unstructured":"Adler AF, Cardoso T, Nolbrant S, Mattsson B, Hoban DB, Jarl U et al (2019) hESC-derived dopaminergic transplants integrate into basal ganglia circuitry in a preclinical model of Parkinson\u2019s disease. Cell reports. 28(13):3462\u201373. e5.","DOI":"10.1016\/j.celrep.2019.08.058"},{"issue":"7669","key":"8719_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T et al (2017) Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature 548(7669):592\u2013596","journal-title":"Nature"},{"issue":"1","key":"8719_CR24","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K et al (2020) Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat Commun 11(1):3369","journal-title":"Nat Commun"},{"key":"8719_CR25","doi-asserted-by":"crossref","unstructured":"Kim TW, Piao J, Koo SY, Kriks S, Chung SY, Betel D et al (2021) Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use. Cell stem cell. 28(2):343\u201355. e5.","DOI":"10.1016\/j.stem.2021.01.005"},{"key":"8719_CR26","doi-asserted-by":"crossref","unstructured":"Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N et al (2021) Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell stem cell. 28(2):217\u201329. e7.","DOI":"10.1016\/j.stem.2021.01.004"},{"issue":"38","key":"8719_CR27","doi-asserted-by":"publisher","first-page":"38ra46","DOI":"10.1126\/scitranslmed.3000976","volume":"2","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S et al (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants. Sci Transl Med 2(38):38ra46-38ra46","journal-title":"Sci Transl Med"},{"issue":"1","key":"8719_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","volume":"71","author":"Z Kefalopoulou","year":"2014","unstructured":"Kefalopoulou Z, Politis M, Piccini P, Mencacci N, Bhatia K, Jahanshahi M et al (2014) Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. JAMA Neurol 71(1):83\u201387","journal-title":"JAMA Neurol"},{"issue":"5","key":"8719_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.5966\/sctm.2013-0195","volume":"3","author":"H-K Tan","year":"2014","unstructured":"Tan H-K, Toh C-XD, Ma D, Yang B, Liu TM, Lu J et al (2014) Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. Stem Cells Transl Med 3(5):586\u2013598","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"8719_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.111.256149","volume":"112","author":"H Okano","year":"2013","unstructured":"Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S et al (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112(3):523\u2013533","journal-title":"Circ Res"},{"issue":"11","key":"8719_CR31","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/nbt.1503","volume":"26","author":"T Aasen","year":"2008","unstructured":"Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F et al (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276\u20131284","journal-title":"Nat Biotechnol"},{"issue":"11","key":"8719_CR32","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T et al (2017) Autologous induced stem-cell\u2013derived retinal cells for macular degeneration. N Engl J Med 376(11):1038\u20131046","journal-title":"N Engl J Med"},{"issue":"2","key":"8719_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.stemcr.2016.12.019","volume":"8","author":"SE Marsh","year":"2017","unstructured":"Marsh SE, Yeung ST, Torres M, Lau L, Davis JL, Monuki ES et al (2017) HuCNS-SC human NSCs fail to differentiate, form ectopic clusters, and provide no cognitive benefits in a transgenic model of Alzheimer\u2019s disease. Stem Cell Reports 8(2):235\u2013248","journal-title":"Stem Cell Reports"},{"key":"8719_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev.neuro.31.060407.125547","volume":"31","author":"RN Lemon","year":"2008","unstructured":"Lemon RN (2008) Descending pathways in motor control. Annu Rev Neurosci 31:195\u2013218","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"8719_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","volume":"12","author":"RA Barker","year":"2013","unstructured":"Barker RA, Barrett J, Mason SL, Bj\u00f6rklund A (2013) Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease. Lancet Neurol 12(1):84\u201391","journal-title":"Lancet Neurol"},{"issue":"9","key":"8719_CR36","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","volume":"11","author":"RA Barker","year":"2015","unstructured":"Barker RA, Drouin-Ouellet J, Parmar M (2015) Cell-based therapies for Parkinson disease\u2014past insights and future potential. Nat Rev Neurol 11(9):492\u2013503","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"8719_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","volume":"21","author":"RA Barker","year":"2017","unstructured":"Barker RA, Parmar M, Studer L, Takahashi J (2017) Human trials of stem cell-derived dopamine neurons for Parkinson\u2019s disease: dawn of a new era. Cell Stem Cell 21(5):569\u2013573","journal-title":"Cell Stem Cell"},{"key":"8719_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/546015a","author":"D Cyranoski","year":"2017","unstructured":"Cyranoski D (2017) Trials of embryonic stem cells to launch in China. Nature. https:\/\/doi.org\/10.1038\/546015a","journal-title":"Nature"},{"issue":"1","key":"8719_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","volume":"8","author":"A Morizane","year":"2017","unstructured":"Morizane A, Kikuchi T, Hayashi T, Mizuma H, Takara S, Doi H et al (2017) MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun 8(1):385","journal-title":"Nat Commun"},{"key":"8719_CR40","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-25-00274","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yin P, Chen Q, Zhang Y, Tang Y, Jin W, Yu L (2025) Neurodegenerative diseases and immune system: From pathogenic mechanism to therapy. Neural regeneration research. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00274","journal-title":"Neural regeneration research"},{"issue":"5","key":"8719_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S et al (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409\u2013412","journal-title":"Nat Methods"},{"issue":"3","key":"8719_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","volume":"16","author":"PJ Hallett","year":"2015","unstructured":"Hallett PJ, Deleidi M, Astradsson A, Smith GA, Cooper O, Osborn TM et al (2015) Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease. Cell Stem Cell 16(3):269\u2013274","journal-title":"Cell Stem Cell"},{"issue":"1","key":"8719_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","volume":"11","author":"Y-K Wang","year":"2018","unstructured":"Wang Y-K, Zhu W-W, Wu M-H, Wu Y-H, Liu Z-X, Liang L-M et al (2018) Human clinical-grade parthenogenetic ESC-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson\u2019s disease. Stem Cell Reports 11(1):171\u2013182","journal-title":"Stem Cell Reports"},{"issue":"1","key":"8719_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010026","volume":"8","author":"T Stoddard-Bennett","year":"2019","unstructured":"Stoddard-Bennett T, Reijo Pera R (2019) Treatment of Parkinson\u2019s disease through personalized medicine and induced pluripotent stem cells. Cells 8(1):26","journal-title":"Cells"},{"issue":"6","key":"8719_CR45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.62641\/aep.v52i6.1711","volume":"52","author":"Q Liu","year":"2024","unstructured":"Liu Q, Wang H, Lv S, Zhao Y, Zheng Y, Li G, Wang W (2024) The Combined Use of Levodopa\/Benserazide and Pramipexole Proves Beneficial for Managing Parkinson\u2019s Disease. Actas Espa\u00f1\u00f1olas de Psiquiatr\u00ed\u00eda 52(6):769\u2013776. https:\/\/doi.org\/10.62641\/aep.v52i6.1711","journal-title":"Actas Espa\u00f1\u00f1olas de Psiquiatr\u00ed\u00eda"},{"key":"8719_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2025.116267","volume":"195","author":"B Hu","year":"2025","unstructured":"Hu B, Wang X, Lu S, Ying X (2025) Astudy of bidirectional control of Parkinson\u2019s beta oscillations by basal ganglia. Chaos, Solitons & Fractals 195:116267. https:\/\/doi.org\/10.1016\/j.chaos.2025.116267","journal-title":"Chaos, Solitons & Fractals"},{"key":"8719_CR47","doi-asserted-by":"crossref","unstructured":"Normile D (2018) First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson\u2019s. Science. 80(10.1126).","DOI":"10.1126\/science.aau9466"},{"issue":"10","key":"8719_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","volume":"36","author":"A Louveau","year":"2015","unstructured":"Louveau A, Harris TH, Kipnis J (2015) Revisiting the mechanisms of CNS immune privilege. Trends Immunol 36(10):569\u2013577","journal-title":"Trends Immunol"},{"issue":"8","key":"8719_CR49","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood-2013-03-478255","volume":"122","author":"H Torikai","year":"2013","unstructured":"Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y et al (2013) Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood 122(8):1341\u20131349","journal-title":"Blood"},{"issue":"1","key":"8719_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.stem.2013.11.014","volume":"14","author":"Z Rong","year":"2014","unstructured":"Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H et al (2014) An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell 14(1):121\u2013130","journal-title":"Cell Stem Cell"},{"issue":"8","key":"8719_CR51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse GG, Hirata RK, Funk SE, Riolobos L, Lopes VS, Manske G et al (2017) HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol 35(8):765\u2013772","journal-title":"Nat Biotechnol"},{"key":"8719_CR52","doi-asserted-by":"crossref","unstructured":"Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N et al (2019) Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell stem cell. 24(4):566\u201378. e7.","DOI":"10.1016\/j.stem.2019.02.005"},{"key":"8719_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","volume":"13","author":"J Takahashi","year":"2020","unstructured":"Takahashi J (2020) iPS cell-based therapy for Parkinson\u2019s disease: a Kyoto trial. Regen Ther 13:18\u201322","journal-title":"Regen Ther"},{"issue":"20","key":"8719_CR54","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, Song B, Herrington TM, Park T-Y, Lee N, Ko S et al (2020) Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med 382(20):1926\u20131932","journal-title":"N Engl J Med"},{"issue":"5","key":"8719_CR55","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","volume":"37","author":"SJ Chinta","year":"2005","unstructured":"Chinta SJ, Andersen JK (2005) Dopaminergic neurons. Int J Biochem Cell Biol 37(5):942\u2013946","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"8719_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27(3):275\u2013280","journal-title":"Nat Biotechnol"},{"issue":"7378","key":"8719_CR57","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim J-W, Piao J, Ganat YM, Wakeman DR, Xie Z et al (2011) Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD. Nature 480(7378):547","journal-title":"Nature"},{"issue":"10","key":"8719_CR58","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/stem.499","volume":"28","author":"A Swistowski","year":"2010","unstructured":"Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L et al (2010) Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28(10):1893\u20131904","journal-title":"Stem Cells"},{"issue":"5","key":"8719_CR59","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","volume":"136","author":"F Soldner","year":"2009","unstructured":"Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG et al (2009) Parkinson\u2019s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5):964\u2013977","journal-title":"Cell"},{"key":"8719_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.redox.2013.12.013","volume":"2","author":"S Giordano","year":"2014","unstructured":"Giordano S, Darley-Usmar V, Zhang J (2014) Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol 2:82\u201390","journal-title":"Redox Biol"},{"issue":"3","key":"8719_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.mcn.2010.06.017","volume":"45","author":"O Cooper","year":"2010","unstructured":"Cooper O, Hargus G, Deleidi M, Blak A, Osborn T, Marlow E et al (2010) Differentiation of human ES and Parkinson\u2019s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci 45(3):258\u2013266","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"8719_CR62","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","volume":"31","author":"C Zhou","year":"2024","unstructured":"Zhou C, Kuang M, Tao Y, Wang J, Luo Y, Fu Y, Hou Y (2024) Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. Cell Stem Cell 31(9):1359\u20131375. https:\/\/doi.org\/10.1016\/j.stem.2024.06.007","journal-title":"Cell Stem Cell"},{"key":"8719_CR63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.freeradbiomed.2014.06.014","volume":"74","author":"C-M Chong","year":"2014","unstructured":"Chong C-M, Shen M, Zhou Z-Y, Pan P, Hoi P-M, Li S et al (2014) Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP+-induced oxidative stress and cell death in SH-SY5Y cells. Free Radic Biol Med 74:283\u2013293","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"8719_CR64","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1212\/01.WNL.0000113727.73153.68","volume":"62","author":"J Benito-Leon","year":"2004","unstructured":"Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez J, Porta-Etessam J, Trincado R, Vega S et al (2004) Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 62(5):734\u2013741","journal-title":"Neurology"},{"issue":"7","key":"8719_CR65","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/01.WNL.0000140706.52798.BE","volume":"63","author":"L De Lau","year":"2004","unstructured":"De Lau L, Giesbergen P, De Rijk M, Hofman A, Koudstaal P, Breteler M (2004) Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam study. Neurology 63(7):1240\u20131244","journal-title":"Neurology"},{"issue":"6","key":"8719_CR66","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.14336\/AD.2018.1026","volume":"9","author":"AK Shetty","year":"2018","unstructured":"Shetty AK, Kodali M, Upadhya R, Madhu LN (2018) Emerging anti-aging strategies-scientific basis and efficacy. Aging Dis 9(6):1165","journal-title":"Aging Dis"},{"issue":"5","key":"8719_CR67","doi-asserted-by":"publisher","first-page":"785","DOI":"10.14336\/AD.2017.1028","volume":"9","author":"Y-F Zhao","year":"2018","unstructured":"Zhao Y-F, Zhang J-F, Lou Z-Y, Zu H-B, Wang Z-G, Zeng W-C et al (2018) The synergy of aging and LPS exposure in a mouse model of Parkinson\u2019s disease. Aging Dis 9(5):785","journal-title":"Aging Dis"},{"issue":"1","key":"8719_CR68","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, Von Saucken VE et al (2015) Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun 6(1):7314","journal-title":"Nat Commun"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08719-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:03:51Z","timestamp":1771347831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08719-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["8719"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08719-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"190"}}